Global Next Generation Immunotherapy Market: In-Depth Analysis and Forecasts for 2024-2029
MarkNtel Advisors, a leading market research firm, has showed its latest study titled “Next Generation Immunotherapy Market“, offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Analysis and Insights into the Next Generation Immunotherapy Market: 2024-2029
Global Next Generation Immunotherapy Market is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2024-29. Some of the key factors propelling the market growth included the rising burden of chronic diseases, increasing research in the area of next-generation drugs, and an increased focus on targeted therapies for certain diseases. Also, the factor majorly affecting the Global Next Generation Immunotherapy Market was the rising prevalence of chronic diseases like asthma, allergic conditions, cancer, and multiple sclerosis.
Request Free Sample of the Report – https://www.marknteladvisors.com/query/request-sample/next-generation-immunotherapy-market.html
What are the primary factors driving the growth of the Next Generation Immunotherapy Market?
Growing Adoption of Chimeric Antigen Receptor (CAR) T-cell Therapy – In recent years, there has been a high demand for chimeric antigen receptor (CAR) T-cell therapy, which has been majorly driven by the rising prevalence of relapsed B-cell acute lymphoblastic leukemia (ALL) and specific non-Hodgkin lymphomas. For instance,
- In 2020, according to the GLOBOCON, non-Hodgkin lymphomas (NHL) have been ranked as one of the most common cancers and had an estimated 544,000 new cancer cases and 260,000 cancer deaths in 2020.
The rising demand for CAR-T cell therapy among NHL patients has been majorly attributed to the superior clinical outcomes of chimeric antigen receptor (CAR) T-cell therapy arising from its proven success in treating challenging conditions. In addition, to cater to this rising demand for CAR-T cell therapy, companies have heightened funding into CAR-T cell therapy research & development, which led to the launch of new drugs. For instance,
- In 2020, Tecartus, by Kite Pharma Inc., a CAR-T cell therapy was approved by the US FDA, which provided a significant treatment option for relapsed or refractory mantle cell lymphoma, expanding the application of CAR-T cell therapies of non-Hodgkin lymphoma.
Hence, with the availability of better next-generation immunotherapies, the market has experienced considerable growth. Moreover, the regulatory approvals and accelerated pathways granted by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have played a crucial role in driving the adoption of CAR-T cell therapy. Hence, the established regulatory framework and clear pathways for approval would further facilitate the development and commercialization of CAR-T cell therapies, which would help in the market growth in the coming years as well.
Next Generation Immunotherapy Market Segmentation:
The Next Generation Immunotherapy market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.
By Type
- Vaccines- Market Size & Forecast 2019-2029F, USD Million
- mRNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
- DNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
- Protein Vaccines- Market Size & Forecast 2019-2029, USD Million
- Others (Viral Vector Vaccines, Nanoparticle Vaccines, etc.)- Market Size & Forecast 2019-2029, USD Million
- Immune Checkpoint Modulators- Market Size & Forecast 2019-2029F, USD Million
- CAR-T Cell Therapy- Market Size & Forecast 2019-2029F, USD Million
- Tumor-Infiltrating Lymphocytes (TILs) Therapy- Market Size & Forecast 2019-2029F, USD Million
- Bispecific Antibodies- Market Size & Forecast 2019-2029F, USD Million
- Oncolytic Virus Therapy- Market Size & Forecast 2019-2029F, USD Million
- Others (Antibody-drug Conjugates, ACE Inhibitors, etc.)- Market Size & Forecast 2019-2029F, USD Million
By Route of Administration
- Intravenous- Market Size & Forecast 2019-2029F, USD Million
- Intratumoral- Market Size & Forecast 2019-2029F, USD Million
- Subcutaneous- Market Size & Forecast 2019-2029F, USD Million
- Oral- Market Size & Forecast 2019-2029F, USD Million
By Therapeutic Area
- Oncology- Market Size & Forecast 2019-2029F, USD Million
- Autoimmune Diseases- Market Size & Forecast 2019-2029F, USD Million
- Infectious Diseases- Market Size & Forecast 2019-2029F, USD Million
- Inflammatory Diseases- Market Size & Forecast 2019-2029F, USD Million
- Others (Neurological Disorders, B-cell Malignancies, etc.) – Market Size & Forecast 2019-2029F, USD Million
By End User
- Hospitals- Market Size & Forecast 2019-2029F, USD Million
- Specialty Clinics- Market Size & Forecast 2019-2029F, USD Million
- Ambulatory Surgical Centres- Market Size & Forecast 2019-2029F, USD Million
- Cancer Research Centres- Market Size & Forecast 2019-2029F, USD Million
Geographical Analysis into the Next Generation Immunotherapy Market:
The Next Generation Immunotherapy market is categorized based regional:
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
View Full Report [Including Description + TOC] – https://www.marknteladvisors.com/research-library/next-generation-immunotherapy-market.html
Competitive Landscape and Next Generation Immunotherapy Market Share Analysis:
The competitive landscape of the Next Generation Immunotherapy Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.
- Bristol Myers Squibb
- Regeneron Pharmaceuticals
- MacroGenics
- AbbVie Inc.
- Pfizer Inc.,
- Novartis, Merck & Co., Inc.
- AstraZeneca
- Incyte Corporation
- Eli Lilly and Company
- Johnson and Johnson
- Others
Sent Customized Report Inquiry – https://www.marknteladvisors.com/query/request-customization/next-generation-immunotherapy-market.html
Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Questions Addressed in this Study
- What factors are driving the Next Generation Immunotherapy Market growth?
- How is the Next Generation Immunotherapy Market expected to grow over the next five years?
- What are the key insights into the current trends in the Next Generation Immunotherapy Market?
- What is the current size of the Next Generation Immunotherapy Market, and how is it projected to change in the future?
- What is the future outlook for the Next Generation Immunotherapy Market in terms of technological advancements and market expansion?
Why choose MarkNtel?
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.
Contact Us –
Call: +1 628 895 8081 +91 120 4278433
Email: sales@marknteladvisors.com
Visit to know more: https://www.marknteladvisors.com/